Clinical Trial Update: Short Course Regimens for Treatment of PKDL (Sudan) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on short course regimens for post-kala-azar dermal leishmanoid (PKDL) in Sudan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-kala-azar Dermal Leishmanioid Disease

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: PKDL - Post-Kala-Azar Dermal Leishmanioid | Phase 2 | Status: UNKNOWN